Brief: Camurus Receives Approval In Canada For Oczyesa XR
Oct 12 (Reuters) - Camurus ABCAMX.ST : * CAMURUS RECEIVES APPROVAL IN CANADA FOR OCZYESA® XR, A ONCE-MONTHLY, SELF-ADMINISTERED TREATMENT FOR ACROMEGALY Source text:ID:nWkrfSFgf Further company coverage:CAMX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat